These studies suggested that the pretreatment of Forsythiaside could efficiently act on the kidney to keep podocytes functioning normally through targeting RHOA and PRKCA and could be developed as a potential natural antioxidant and therapy for DKD podocyte injury by controlling mTOR signaling pathways. The gene discussed is RHOA; the disease is diabetic kidney disease.